Preparation method and application of tuna collagen oligopeptide with whitening and antioxidant functions

Through composite cleaning and multi-enzymatic treatment, high content of small molecular weight tuna collagen oligomeric peptides were prepared, solving the problems of large molecular weight and time-consuming removal of oil in the prior art, and achieving better whitening, antioxidant and anti-aging effects.

CN119082244APending Publication Date: 2024-12-06ZHEJIANG PINGTAIRONG BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411211098.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-30
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

When preparing collagen oligomeric peptides in existing tuna skins, the molecular weight is relatively large and the content of small molecular weight peptides is low, which affects its anti-photoaging, antioxidant and anti-fatigue effects, and the oil removal process is time-consuming and the effect is not ideal.

Method used

Use a composite cleaning agent and horizontal stirring to remove the fat of the fish skin. Then use chymotrypsin and alkaline protease to be enzymatically dissolved at low temperature. Then add bromelain and flavor protease to treat it, combining enzyme inactivation, decolorization, desalination, and desalination. and spray drying step to prepare high content of small molecular weight tuna collagen oligopeptide.

Benefits of technology

Improve the whitening, antioxidant and anti-aging effects of tuna collagen oligopeptide, and the prepared collagen oligopeptide powder has a good taste, a light fishy smell, a high content of characteristic amino acid-hydroxyproline, and has better utilization rate and Effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119082244A_ABST
    Figure CN119082244A_ABST
Patent Text Reader

Abstract

The invention provides a method for preparing tuna collagen oligopeptide, which comprises the following steps: 1) carrying out degreasing treatment on tuna skin to obtain a substance to be subjected to enzymolysis; and 2) carrying out the following treatment on the to-be-enzymolyzed product: i) adding chymotrypsin and alkaline protease into the to-be-enzymolyzed product, and carrying out enzymolysis at 30-40 DEG C for 20-60 minutes; and ii) adding bromelain and flavourzyme, and carrying out enzymolysis at 50-60 DEG C for 3-5 hours to obtain an enzymolysis product. The tuna collagen oligopeptide prepared by the method has relatively high whitening, anti-oxidation and anti-aging capabilities.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to collagen oligopeptide prepared from tuna skin and also relates to the application of the collagen oligopeptide in whitening and anti-aging. Background Art

[0002] Tuna is a large marine fish that swims rapidly throughout its life to obtain oxygen, so it also stores a variety of nutrients. Studies have found that tuna is rich in various amino acids and trace elements (such as selenium and taurine) to meet the nutrient supply and fatigue relief required for this strenuous and rapid exercise.

[0003] Tuna can be caught by longline fishing, purse seine fishing, pole fishing, etc. Longline tuna is usually caught in waters at a depth of about 200 meters. The species caught include longfin, yellowfin, bigeye, etc. The caught tuna is usually transported and stored at ultra-low temperatures (below -50°C) to maintain the high nutritional quality of the raw materials. After rough processing of longline tuna, about 50% of the naked fish is used as fresh sashimi, and the remaining heads, skins, minced meat, etc. are developed into fish meal feed or protein peptides.

[0004] Tuna skin is covered with a thick layer of scales that are difficult to fall off, and the fish skin is rich in oil, accounting for about 10% of the fresh fish skin. Incomplete oil treatment will affect the taste and storage quality of the peptide powder, and it needs to be pre-treated to remove the oil. Oil removal is usually steaming or single alkali washing. The steaming time is long to make the oil dissolve more thoroughly, which is time-consuming, and the effect of single alkali washing is not ideal. At present, tuna skin is mostly processed into collagen, collagen peptides, protein peptides, etc. The prepared polypeptide has a large molecular weight, and the content of small molecular weight (<1000Da) peptides is low. The large molecular weight affects the effect. Existing studies have shown that tuna peptides have anti-photoaging, anti-oxidation, anti-fatigue and other effects, but the utilization rate and effect need to be further improved. Summary of the invention

[0005] In one aspect, the present invention provides a method for preparing tuna collagen oligopeptide, comprising:

[0006] 1) degreasing tuna skin to obtain a product to be hydrolyzed; and

[0007] 2) The product to be hydrolyzed is treated as follows:

[0008] i) adding chymotrypsin and alkaline protease to the product to be hydrolyzed, and performing enzymolysis at 30-40° C. for 20-60 minutes; and

[0009] ii) adding bromelain and flavor protease, performing enzymolysis at 50-60° C. for 3-5 hours to obtain an enzymolysis product.

[0010] In some embodiments, the degreasing treatment includes washing the fish skin with a mixed solution of 8% sodium chloride and 8% sodium bicarbonate, soaking in a 5% citric acid solution, and extracting gelatin with hot water.

[0011] In some embodiments, the final concentrations of chymotrypsin and alkaline protease in the material to be enzymolyzed are 0.5% and 0.2%, respectively.

[0012] In some embodiments, step i) further comprises inactivating the chymotrypsin and alkaline protease after enzymatic hydrolysis.

[0013] In some embodiments, the enzymatic hydrolysis temperature in step i) is 35° C. and the enzymatic hydrolysis time is 30 min.

[0014] In some embodiments, the final concentration of bromelain and flavor protease in the material to be enzymolyzed is 0.3%.

[0015] In some embodiments, the enzymatic hydrolysis temperature in step ii) is 55° C. and the enzymatic hydrolysis time is 4 h.

[0016] In some embodiments, the method further comprises step 3): removing fishy smell, desalting, concentrating and spray drying the enzymatic hydrolysis product to obtain tuna collagen oligopeptide powder.

[0017] On the other hand, the present invention provides the use of the tuna collagen oligopeptide prepared by the above method in whitening and / or anti-oxidation and / or anti-aging. The use can be for therapeutic purposes or non-therapeutic purposes. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 The results of the toxicity test of the tuna collagen oligopeptide powder prepared by the present invention on B16-f10 cells are shown.

[0019] Figure 2 The results of the toxicity test of the tuna collagen oligopeptide powder prepared by the present invention on Hacat cells are shown.

[0020] Figure 3 The results of the test on the inhibition of tyrosinase activity of B16-f10 cells by the tuna collagen oligopeptide powder prepared by the present invention are shown.

[0021] Figure 4 The effect of the tuna collagen oligopeptide powder prepared by the present invention on the GSH-Px activity in B16-f10 cells is shown.

[0022] Figure 5 The effect of the tuna collagen oligopeptide powder prepared by the present invention on the SOD activity in B16-f10 cells is shown.

[0023] Figure 6The effect of the tuna collagen oligopeptide powder prepared by the present invention on the MDA level in B16-f10 cells is shown.

[0024] Figure 7 The photographs are shown to show the effect of the tuna collagen oligopeptide powder prepared by the present invention on the level of reactive oxygen species (ROS) in B16-f10 cells.

[0025] Figure 8 The results of quantitative detection of the effect of the tuna collagen oligopeptide powder prepared by the present invention on the level of reactive oxygen species (ROS) in B16-f10 cells are shown.

[0026] Fig. 9 The results show that the tuna collagen oligopeptide powder prepared by the present invention performs oxidative repair on Hacat cells treated with H2O2.

[0027] Fig.10 Representative photographs showing that the tuna collagen oligopeptide powder prepared by the present invention reduces apoptosis of Hacat cells treated with H2O2.

[0028] Fig.11 Representative photos showing that the tuna collagen oligopeptide powder prepared by the present invention reduces the senescence of Hacat cells treated with H2O2.

[0029] Fig.12 The results show the effect of the tuna collagen oligopeptide powder prepared by the present invention on the β-galactosidase activity in Hacat cells treated with H2O2.

[0030] Fig.13 The results show the effect of the tuna collagen oligopeptide powder prepared by the present invention on the activity of the antioxidant enzyme HO-1 in Hacat cells treated with H2O2.

[0031] Fig.14 The results show the effect of the tuna collagen oligopeptide powder prepared by the present invention on the activity of the antioxidant enzyme NQO1 in Hacat cells treated with H2O2. DETAILED DESCRIPTION

[0032] Unless defined otherwise, all technical and scientific terms used herein have the same meanings as commonly understood by one of ordinary skill in the art.

[0033] In this document, the term "and / or" should be understood to mean either one or both of the alternatives.

[0034] In this document, the terms "include" and "comprising" generally mean including the elements explicitly specified but not excluding other elements, and also include the situation consisting of these elements.

[0035] As used herein, the term "about" generally refers to variations within a range of 0.5%-10% above or below a specified value, for example, 0.5%, 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 5.5%, 6%, 6.5%, 7%, 7.5%, 8%, 8.5%, 9%, 9.5%, or 10% above or below a specified value.

[0036] Unless otherwise indicated, percentages and ratios herein are by weight.

[0037] On the one hand, the present invention provides a method for treating tuna skin, which adopts a composite cleaning agent and horizontal stirring cleaning to fully remove the grease in the fish skin, and then soaks it in a citric acid solution and facilitates subsequent enzymatic hydrolysis, thereby increasing the proportion of small molecular weight oligopeptides in the enzymatic hydrolysate.

[0038] On the other hand, the present invention provides a method for enzymatically treating the fish skin treated by the above method, which includes using chymosin and alkaline protease to treat for a short time (20-60min) at a relatively low temperature (30-40°C), then deactivating the enzyme, and then treating with bromelain and flavor protease at 50-60°C for a longer time (3h-5h). Compared with the conventional method (such as using alkaline protease and flavor protease to hydrolyze in sequence) to prepare tuna collagen oligopeptide powder, the tuna collagen oligopeptide powder prepared by the enzymatic hydrolysis method has a strong ability to inhibit cell melanin production, enhance cell SOD activity and oxidative repair ability, and has better whitening and anti-aging effects. The use method of the tuna collagen oligopeptide powder of the present invention includes mixing with appropriate cosmetic excipients for external application on the skin, or mixing with edible or medicinal excipients for oral administration.

[0039] The tuna collagen oligopeptide powder prepared by the method of the invention has good taste, light fishy smell and high content of characteristic amino acid-hydroxyproline.

[0040] The present invention is described below by means of specific examples.

[0041] All experimental results were statistically analyzed using Excel software and significance analysis was performed using IBM SPSS Statistics 27.0.1 software.

[0042] Example 1 Tuna Skin Processing

[0043] The longline ultra-low temperature frozen tuna skin is used as raw material, and is washed with a mixed solution containing 8% sodium chloride and 8% sodium bicarbonate, with a material-liquid ratio of 1:10, and washed with horizontal stirring for 30 minutes, repeated 3 times, the waste water is discharged and washed with water until neutral, and then soaked in 5% citric acid solution for 2 hours. Then, it is washed with water until neutral, pure water is added at a material-liquid ratio of 1:8, and heated to 90°C for 2 hours to extract colloid. The waste residue and upper layer of fat are discharged to obtain the feed solution to be enzymolyzed.

[0044] Example 2 Enzymatic treatment and preparation of tuna collagen oligopeptide powder

[0045] The enzymolysis solution prepared in Example 1 was subjected to step-by-step enzymolysis treatment. The enzymolysis process is as follows:

[0046] 1) adding chymosin and alkaline protease to the solution to be hydrolyzed to a final concentration of 0.5% and 0.2%, respectively, and performing enzymolysis at 35°C for 30 minutes, and then immediately heating to 85°C for 10 minutes to inactivate the protease;

[0047] 2) Bromelain (Hunan Yunbang Biological) and flavor protease (Nanning Dongheng Huadao) were added to a final concentration of 0.3% and enzymolysis was carried out at 55° C. for 4 hours.

[0048] After the enzymatic hydrolysis is completed, the enzyme is inactivated at 85°C, and 2% activated carbon is added to the liquid for decolorization and deodorization for 30 minutes. Plate and frame filtration is adopted, and the plate and frame are pre-coated with 0.05-0.1cm thick activated white clay. The filtered liquid is desalted by nanofiltration (nanofiltration membrane 50nm). After the desalination is completed, vacuum concentration is carried out, and the concentration temperature is 80°C. The liquid is concentrated to 30%, and spray drying is performed to obtain tuna collagen oligopeptide powder. The oil content in the tuna collagen oligopeptide powder is less than 0.043% detected by Soxhlet extraction method. HPLC determination shows that the oligopeptides with a relative molecular weight of less than 1000Da account for about 91% of the tuna collagen oligopeptide powder, and the oligopeptides with a relative molecular weight of less than 500Da account for about 43%.

[0049] Example 3 Enzymatic treatment (Comparative example)

[0050] In this example, the enzymatic hydrolysis method of Example 2 was used to prepare tuna collagen oligopeptide powder, except that the protease was not inactivated at 85° C. in step 1).

[0051] Example 4 Enzymatic treatment (Comparative example)

[0052] In this example, the enzymatic hydrolysis method of Example 2 was used to prepare tuna collagen oligopeptide powder, except that the enzymatic hydrolysis time in step 1) was extended to 2 hours.

[0053] Example 5 Enzymatic treatment (Comparative example)

[0054] In this example, the enzymatic hydrolysis method of Example 2 was used to prepare tuna collagen oligopeptide powder, except that the enzymatic hydrolysis was performed at 55° C. in step 1).

[0055] Example 6 Enzymatic treatment (Comparative example)

[0056] This example adopts the enzymatic hydrolysis method of Example 2 to prepare tuna collagen oligopeptide powder, except that only chymosin is used in step 1).

[0057] Example 7 Enzymatic treatment (Comparative example)

[0058] This example adopts the enzymatic hydrolysis method of Example 2 to prepare tuna collagen oligopeptide powder, except that only alkaline protease is used in step 1).

[0059] Example 8 Enzymatic treatment (Comparative example)

[0060] This example adopts the enzymatic hydrolysis method of Example 2 to prepare tuna collagen oligopeptide powder, except that only bromelain is used in step 2).

[0061] Example 9 Enzymatic treatment (Comparative example)

[0062] This example adopts the enzymatic hydrolysis method of Example 2 to prepare tuna collagen oligopeptide powder, except that only flavor protease is used in step 2).

[0063] Example 10 Enzymatic treatment (Comparative example)

[0064] In this example, the enzymatic hydrolysis method of Example 2 was used to prepare tuna collagen oligopeptide powder, except that only alkaline protease was used in step 1) and only flavor protease was used in step 2).

[0065] Example 11 Enzymatic treatment (Comparative example)

[0066] This example adopts the enzymatic hydrolysis method of Example 2 to prepare tuna collagen oligopeptide powder, except that only step 1) is performed.

[0067] Example 12 Enzymatic treatment (Comparative example)

[0068] This example adopts the enzymatic hydrolysis method of Example 2 to prepare tuna collagen oligopeptide powder, except that only step 2) is performed.

[0069] Example 13 Cytotoxicity Test

[0070] Cytotoxicity assays were performed using B16-f10 cells (mouse skin melanoma cells) and Hacat cells (human immortalized keratinocytes).

[0071] For B16-f10 cells, the test sample concentration (concentration in culture medium) was set to: 0.01 mg / mL, 0.1 mg / mL, 0.5 mg / mL and 1 mg / mL. The cells were seeded in a 96-well plate and administered 24 hours later. Cytotoxicity was detected using a CCK-8 kit 48 hours after administration. The results showed that the tuna collagen oligopeptide powder prepared in any of the above Examples 2-12 was non-toxic to B16-f10 cells at a concentration of up to 1 mg / mL. Representative results are shown in Figure 1 There was no significant difference in the survival rate of tuna collagen oligopeptide compared with the blank without oligopeptide powder, and there was no significant difference between the groups. Therefore, the subsequent experiments on B16-f10 cells were mainly carried out at a concentration of 1 mg / mL.

[0072] For Hacat cells, the test sample concentration (concentration in culture medium) was set to: 0.01 mg / mL, 0.1 mg / mL and 1 mg / mL. The cells were seeded in a 96-well plate and administered 24 hours later. Cytotoxicity was detected using a CCK-8 kit 48 hours after administration. The results showed that the tuna collagen oligopeptide powder prepared in any of the above Examples 2-12 was non-toxic to Hacat cells at a concentration of up to 1 mg / mL. Representative results are shown in Figure 2 There was no significant difference in the survival rate of tuna collagen oligopeptide compared with the blank without oligopeptide powder, and there was no significant difference between the groups. Therefore, the subsequent experiments on Hacat cells were mainly carried out at a concentration of 1 mg / mL.

[0073] In addition, similarly, we also conducted cytotoxicity experiments on positive drugs α-Arbutin (α-Arbutin) and N-acetylcysteine ​​(NAC) and hydrogen peroxide. The results showed that at a concentration of 0.01 mg / mL, α-Arbutin was non-toxic to B16-f10 cells, but when the concentration increased to 0.1 mg / mL, the cell survival rate was 81.62%. As the concentration gradually increased, the cell survival rate gradually decreased. The cell survival rates at concentrations of 0.5 mg / mL and 1 mg / mL were 50.48% and 46.57%, respectively. Therefore, subsequent experiments were conducted at a concentration of 0.01 mg / mL.

[0074] The dosing concentrations of N-acetylcysteine ​​(NAC) were set to: 0.0815 mg / mL, 0.163 mg / mL, 0.251 mg / mL and 0.326 mg / mL. Hacat cells were first planted in a 96-well plate and administered 24 hours later. A cytotoxicity experiment was performed using the CCK-8 experimental method 24 hours after administration. The results showed that 0.0815, 0.163, 0.251, and 0.326 mg / mL of NAC had no cytotoxicity, and the cell survival rates were all greater than 90%, so subsequent experiments were conducted with a NAC drug concentration of 0.326 mg / mL.

[0075] The H2O2 administration concentration was set to: 100, 125, 150, 200 μM. First, the cells were planted in a 96-well plate, and hydrogen peroxide was administered after 24 hours. After 4 hours of administration, the medium was replaced with a medium without hydrogen peroxide and continued to be cultured for 24 hours. The cytotoxicity experiment was performed using the CCK-8 detection method. The results showed that at a concentration of 100 μM, the cell survival rate was 69.68%, which was toxic to the cells. When the concentration increased to 125 μM, the cell survival rate was 60.61%. As the concentration gradually increased, the cell survival rate gradually decreased. The cell survival rates at concentrations of 150 μM and 200 μM were 51.13% and 35.22%, respectively. Subsequent experiments were performed at a 150 μM H2O2 administration concentration.

[0076] Example 13 Melanin production inhibition test

[0077] In this example, B16-f10 cells were used to perform an experiment to inhibit melanin production. The melanin content of cells was measured by alkaline lysis method when the drug was administered and when it was not administered, and the ability of tuna collagen oligopeptides to inhibit melanin production was detected.

[0078] Experimental process: The cells were inoculated in a 96-well plate and cultured overnight in an incubator at 37°C with 5% CO2. The tuna collagen oligopeptide prepared in Example 2-12 was added to the experimental group (1 mg / mL), α-arbutin (α-Arbutin) (0.01 mg / mL) was added to the positive group, and no drug was added to the blank group. After continuing to culture for 48 hours, the cells were collected into a sterile EP tube, centrifuged at 2500rpm / min for 5 minutes, the supernatant was poured out, and washed with PBS 3 times. After pouring out the supernatant, 1 mol / L NaOH (containing 10% DMSO) was added to each EP tube, and then pure water was added. The mixed solution was blown evenly and transferred to a 96-well plate, and the mixed solution was added to each well. The absorbance value was measured at 490nm on the microplate reader. Five replicate wells were set for each concentration. The melanin synthesis inhibition rate (%) in the melanocytes in each well was calculated according to the following formula.

[0079] Melanin synthesis inhibition rate (%) = [1-(OD value of drug group) / (OD value of blank control group)] × 100%.

[0080] The results are listed in Table 1.

[0081] Table 1. Inhibitory effect of tuna collagen oligopeptides prepared in various examples on melanin synthesis in B16-f10 cells

[0082]

[0083]

[0084] From the results in Table 1, it can be seen that the tuna collagen oligopeptide prepared in Example 2 has the best inhibitory effect (inhibition rate 26.8%), and there is a significant difference in inhibitory effect between it and the tuna collagen oligopeptide prepared in Example 3 (inhibition rate 18.3%) which has the second best performance (p<0.01), and it is better than α-arbutin at a concentration of 0.01 mg / mL.

[0085] Example 14 Tyrosinase Activity Inhibition Test

[0086] Take B16-F10 cells, inoculate them in a 96-well plate, place the cells in an incubator at 37°C and 5% CO2, and culture overnight. Add different concentrations of tuna collagen oligopeptide and α-arbutin (0.01 mg / mL) prepared in Example 2 to the experimental wells, and no drugs are added to the blank wells. Each experimental group is set up with 5 replicate wells. The cells are cultured in an incubator at 37°C and 5% CO2 for 48 hours. The supernatant is sucked off, rinsed 3 times with PBS, and then 1% (v / v) TritonX-100 solution is added to each well. The 96-well plate is sealed with a sealing film and placed in a refrigerator at -80°C for 1 hour, then the culture plate is taken out and placed at room temperature to melt and lyse the cells, and a final concentration of 0.5% levodopa is added to each well. The culture plate is incubated at 37°C for 2 hours, and the absorbance value is measured at 490nm on an ELISA reader. The percentage of tyrosinase activity in each experimental well was calculated according to the following formula (the blank control group was recorded as 100%).

[0087] Tyrosinase activity (%) = (OD value of drug group) / (OD value of blank control group) × 100%.

[0088] The results are shown in Figure 3 After the positive drug α-Arbutin was administered, the tyrosinase activity dropped to 78.8%. After the tuna collagen oligopeptide was administered, the tyrosinase activity dropped to 74.7%. The tuna collagen oligopeptide group showed a significant decrease compared with the blank group (p<0.001). The above results are also consistent with the experimental results of Example 13.

[0089] Example 15 Antioxidant effect of tuna collagen oligopeptide

[0090] In this example, B16-f10 cells were used to verify the antioxidant effect of the tuna collagen oligopeptide prepared in Example 2 in a variety of detection methods.

[0091] 15.1 Glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) activity detection and malondialdehyde (MDA) content detection

[0092] The concentration of tuna collagen oligopeptide and α-Arbutin were screened by the above toxicity experiment. The concentration of α-Arbutin was 0.01 mg / mL, and the concentration of tuna collagen oligopeptide was set to 0.01 mg / mL, 0.1 mg / mL and 1 mg / mL. A blank control group without drug administration was also set. Five replicates were set for each concentration. Drug administration was performed 24 hours after cell inoculation, and samples were collected 48 hours after drug administration. The cells were removed, rinsed with PBS and treated with cell lysis buffer (PMSF containing RIPA), then centrifuged at 12000 rpm / min for 10 minutes, and the supernatant was taken for SOD activity (nitroblue tetrazolium (NBT) method) and MDA level (thiobarbituric acid (TBA) method). For GSH-Px activity detection (DTNB method), the supernatant of the cells was directly taken for centrifugation and detection without rinsing with PBS and treating with cell lysis buffer.

[0093] The results of GSH-Px activity detection were shown in Figure 4 Tuna collagen oligopeptide increased GSH-Px activity by 6.36%, 8.22%, and 10.75% at three concentrations, respectively. At 0.1 mg / mL, GSH-Px activity increased significantly compared with the blank group (p<0.05). When the concentration reached 1 mg / mL, GSH-Px activity increased more significantly compared with the blank group (p<0.01). This shows that the tuna collagen oligopeptide prepared by the present invention can increase GSH-Px activity in cells, and has concentration dependence.

[0094] The results of SOD activity test were shown in Figure 5 Tuna collagen oligopeptide increased SOD activity by 8.25%, 17.32%, and 25.29% at three concentrations, respectively. There were significant differences compared with the control group at all three concentrations, and the difference became more significant as the concentration increased. In terms of SOD activity enhancement, 0.1 mg / mL tuna collagen oligopeptide was equivalent to 0.01 mg / mL α-Arbutin, and higher concentrations of tuna collagen oligopeptide were more effective.

[0095] The results of MDA level detection were shown in Figure 6 Tuna collagen oligopeptide at three concentrations caused MDA levels to decrease by 12.20%, 19.16%, and 31.52%, respectively. 0.01 mg / mL of α-Arbutin caused MDA levels to decrease by 21.2%, which was close to the effect produced by 0.1 mg / mL of tuna collagen oligopeptide.

[0096] The effect of tuna collagen oligopeptide (1 mg / mL) prepared in Example 2-12 on the SOD activity of B16-f10 cells was tested in a similar manner. The results are shown in Table 2 (the activity of the blank group was 100%).

[0097] Table 2. Effects of tuna collagen oligopeptides prepared in various examples on enhancing the SOD activity of B16-f10 cells

[0098] Grouping SOD activity (%, mean) Example 2 128.8 Example 3 125.1 Example 4 117.2 Example 5 108.6 Example 6 115.5 Example 7 112.2 Example 8 113.9 Example 9 114.0 Example 10 115.8 Embodiment 11 104.3 Example 12 111.8

[0099] The tuna collagen oligopeptides prepared in Examples 2 and 3 have significant differences in the effect of enhancing SOD activity compared to the tuna collagen oligopeptides prepared in other examples (p<0.01), while there is no significant difference between them (p>0.05).

[0100] 15.2 Detection of Reactive Oxygen Species (ROS) Levels

[0101] 24 hours after the inoculation of B16-f10 cells, different concentrations of tuna collagen oligopeptides prepared in Example 2 and 0.01 mg / mL α-Arbutin were administered, and qualitative and quantitative detection of ROS was performed 48 hours later. Figure 7 The fluorescence of cells in each group observed under an inverted microscope after staining with DCFH-DA probe is shown. In the figure, the normal group was not treated with drugs; P low: tuna collagen oligopeptide concentration 0.01 mg / mL; P medium: tuna collagen oligopeptide concentration 0.1 mg / mL; P high: tuna collagen oligopeptide concentration 1 mg / mL. Figure 8 The results of quantitative detection of ROS in each group are shown. When the concentration of tuna collagen oligopeptide was 0.1 mg / mL, the ROS content was significantly decreased compared with the blank group (p<0.01), a decrease of 26.0%. When the concentration was 1 mg / mL, the ROS content was extremely significantly decreased compared with the blank group (p<0.001), a decrease of 46.5%. Tuna collagen oligopeptide inhibited ROS generation in a dose-dependent manner.

[0102] Example 16 Tuna collagen oligopeptide repairs oxidative damage caused by H2O2

[0103] In this embodiment, the oxidative damage repair experiment of H2O2 was carried out by Hacat cells (human immortalized epidermal cells). In this experiment, 150μM concentration of hydrogen peroxide was screened out as the median lethal dose of Hacat cells by using the above experiment. First, the cells were planted in a 96-well plate, and 150μM concentration of hydrogen peroxide was given after 24h. After 4h of adding hydrogen peroxide, the culture medium was replaced to remove hydrogen peroxide, and the tuna collagen oligopeptide prepared in Example 2-12 was added at a concentration of 1mg / mL. After 24h, the cell repair effect was detected using the CCK-8 kit. At the same time, a blank group (not treated with hydrogen peroxide and tuna collagen oligopeptide) and a model group (only treated with hydrogen peroxide) were set. Five replicates were set for each group. The survival rate of Hacat cells (blank group) not treated with hydrogen peroxide and tuna collagen oligopeptide was recorded as 100%.

[0104] The results are shown in Table 3.

[0105] Table 3. Effects of tuna collagen oligopeptides prepared in various examples on oxidative repair of Hacat cells

[0106] Grouping Cell survival rate (%, mean) Example 2 76.6 Example 3 61.3 Example 4 58.3 Example 5 58.6 Example 6 59.2 Example 7 62.3 Example 8 63.8 Example 9 56.8 Example 10 59.1 Embodiment 11 53.6 Example 12 54.3 Blank Group 100% Model Group 52.3

[0107] Except that the administration effect of the tuna collagen oligopeptide prepared in Examples 11 and 12 was not significantly different from that of the model group (p>0.05), the other groups were significantly different from the model group (p<0.05), and the administration effect of the tuna collagen oligopeptide prepared in Example 2 was significantly different from that of the other groups (p<0.05).

[0108] Subsequently, the administration effects of different concentrations (0.01 mg / ml, 0.1 mg / ml and 1.0 mg / ml) of the tuna collagen oligopeptide prepared in Example 2 were compared in a similar manner, and a positive drug NAC (0.326 mg / ml) group was set up. The results are shown in Fig. 9 At a concentration as low as 0.01 mg / ml, the tuna collagen oligopeptide administration group prepared in Example 2 had a significant difference from the model group (p<0.05). At a concentration of 0.1 mg / ml, it was equivalent to the positive drug NAC (0.326 mg / ml). Fig.10 The results of cell nucleus staining reflecting cell apoptosis are basically consistent with this. After administering 150 μM concentration of H2O2, the cell nuclei of the model group cells showed a large amount of pyknosis and deformation, indicating a large amount of cell apoptosis. After administering NAC (0.326 mg / mL) positive drug (N-acetylcysteine), the pyknosis and deformation of the cell nuclei were greatly reduced. After administering tuna collagen oligopeptide, the pyknosis and deformation of the cell nuclei were also greatly reduced. It shows that the tuna collagen oligopeptide prepared by the present invention can reduce cell apoptosis and has an anti-apoptotic effect.

[0109] Example 17 Effect of tuna collagen oligopeptide on cell aging

[0110] This example studies the effects of different concentrations of tuna collagen oligopeptides prepared in Example 2 on cell senescence, and compares them with the positive drug NAC.

[0111] Hacat cells were inoculated in a 96-well plate and given 150μM hydrogen peroxide after 24 hours. After 4 hours of adding hydrogen peroxide, the medium was replaced to remove hydrogen peroxide and different concentrations of tuna collagen oligopeptide or NAC (0.326mg / ml) were given. After 24 hours, the β-galactosidase activity (a marker of cell aging) in the cells was detected by the colorimetric substrate X-Gal. Five replicate wells were set for each group. The results are shown in Fig.11 and 12 In. From Fig.11 The representative photos show that after the administration of 150μM H2O2, a large amount of blue appeared in the model group cells, indicating a large amount of cell senescence. After the administration of NAC (0.326mg / mL) positive drug (N-acetylcysteine), the blue color of the cells decreased significantly; after the administration of tuna collagen oligopeptide, the blue color of the cells decreased significantly and was dose-dependent. The quantitative β-galactosidase activity test results are shown in Fig.12 After administration of 150 μM concentration of H2O2, the β-galactosidase activity of the model group was enhanced, which was significantly increased compared with the normal group (p<0.001), indicating that a large number of cell senescence occurred. When the positive drug NAC (0.326 mg / mL) was administered, the β-galactosidase activity decreased, which was significantly different from the model group (P<0.001). After administration of tuna collagen oligopeptide, the β-galactosidase activity was significantly reduced. The three concentration sample groups decreased by 35%, 37.71%, and 46.38%, respectively, which was significantly reduced compared with the model group (p<0.001), and was dose-dependent, indicating that the tuna collagen oligopeptide prepared by the present invention can reduce cell senescence and has an anti-aging effect ( Fig.12 ).

[0112] Example 18 Effect of tuna collagen oligopeptide on antioxidant enzyme activity in Hacat cells

[0113] This example studies the effects of different concentrations of tuna collagen oligopeptides prepared in Example 2 on the activities of antioxidant enzymes HO-1 and NQO1 in Hacat cells, and compares them with the positive drug NAC.

[0114] The cells were treated with hydrogen peroxide and drugs according to Example 17, and the levels of HO-1 and NQO1 in the cell lysate were detected by HO-1 and NQO1 ELISA kits 24 hours after administration. The results are shown in Fig.13 and14 middle.

[0115] After administration of 150 μM H2O2, the level of antioxidant enzyme HO-1 in the model group (MC) decreased, which was significantly different from the blank group (p<0.001). After administration of NAC (0.326 mg / mL), the level of antioxidant enzyme HO-1 in the cells increased, which was significantly different from the model group (p<0.001). After administration of tuna collagen oligopeptide, the level of antioxidant enzyme HO-1 at each concentration increased compared with the model group, which increased by 26.39%, 37.28%, and 43.81%, respectively, and increased with the increase of concentration ( Fig.13 ).

[0116] After administration of 150 μM H2O2, the content of antioxidant enzyme NQO1 in the model group was significantly reduced, which was significantly different from that in the blank group (p<0.001), indicating that the oxidative damage of the cells increased. After administration of NAC (0.326 mg / mL) positive drug, the content of antioxidant enzyme NQO1 in the cells increased, which was significantly different from that in the model group (p<0.001). After administration of tuna collagen oligopeptide, compared with the model group, the cellular antioxidant enzyme NQO1 at each concentration was significantly increased (p<0.01), which was increased by 20.27%, 32.28%, and 38.92%, respectively, indicating that the tuna collagen oligopeptide prepared by the present invention has a good ability to reduce cellular oxidative damage ( Fig.14 ).

Claims

1. A method for preparing tuna collagen oligopeptide, comprising: 1) degreasing tuna skin to obtain a product to be hydrolyzed; as well as 2) The product to be hydrolyzed is treated as follows: i) adding chymotrypsin and alkaline protease to the product to be hydrolyzed, and performing enzymolysis at 30-40° C. for 20-60 minutes; and ii) adding bromelain and flavor protease, performing enzymolysis at 50-60° C. for 3-5 hours to obtain an enzymolysis product.

2. The method of claim 1, wherein the degreasing process comprises using a mixed solution of 8% sodium chloride and 8% sodium bicarbonate to clean the fish skin, soaking in a 5% citric acid solution, and extracting colloid in hot water.

3. The method according to claim 1, wherein the final concentrations of chymotrypsin and alkaline protease in the product to be enzymolyzed are 0.5% and 0.2%, respectively.

4. The method of claim 1, wherein step i) further comprises inactivating the chymotrypsin and alkaline protease after enzymatic hydrolysis.

5. The method according to claim 1, wherein the enzymolysis temperature in step i) is 35°C and the enzymolysis time is 30 min.

6. The method according to claim 1, wherein the final concentration of bromelain and flavor protease in the material to be enzymolyzed is 0.3%.

7. The method according to claim 1, wherein the enzymolysis temperature in step ii) is 55°C and the enzymolysis time is 4 hours.

8. The method according to claim 1, further comprising step 3): removing the fishy smell, desalting, concentrating and spray drying the enzymatic hydrolysate to obtain tuna collagen oligopeptide powder.

9. Use of tuna collagen oligopeptide prepared by the method according to any one of claims 1 to 8 in whitening and / or anti-oxidation and / or anti-aging.